Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2025-10-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether adding vorolanib to atezolizumab will
improve the length of time that participants are cancer-free after receiving standard
chemotherapy.